The Daily Overview on MSN
Eli Lilly closes in on a deal to buy biotech Ventyx
Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...
iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference -- Participation underscores growing excitement around company's momentum and potential in precision oncology ...
Zacks Investment Research on MSN
Merck in talks to buy Revolution Medicines per Financial Times report
A recent Financial Times report stated that Merck MRK is in talks to buy Redwood City, CA-based cancer biotech, Revolution ...
Monte Rosa’s MRT-8102 Phase 1 shows deep NEK7 degradation and strong hsCRP drops; plus $200M raise extends runway. Learn more ...
Verastem, Inc. shifts focus to VS-7375 for KRAS G12D tumors after ending RAMP-203. Click to learn about VSTM's key catalysts ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Mistakes, whether spoken or promised, are universal. The feeling of putting our foot in our mouth arises from a key executive function that our brain controls: stopping ourselves. However, the ...
From Santiago Ramón y Cajal’s hand came branches and whorls, spines and webs. Now-famous drawings by the neuroanatomist in the late 19th and early 20th centuries showed, for the first time, the ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. AKT is the main protein kinase of the PI3K-AKT pathway, interacting with over one ...
Competitive moats give companies a unique business edge, making them attractive to long-term investors. Types of competitive moats include cost, cultural, networking, and resource advantages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results